Eosinophil function in eosinophil-associated gastrointestinal disorders

Current Allergy and Asthma Reports

Volumn 6, Issue 1, 2006, Pages 65-71

  Hogan, Simon P ^a   Rothenberg, Marc E ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; CROMOGLYCATE DISODIUM; CYCLOPHILIN; CYCLOSPORIN A; CYTOKINE ANTIBODY; EOTAXIN ANTIBODY; GLUCOCORTICOID; HYDROXYUREA; INTERLEUKIN 13; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5 ANTIBODY; LECTIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIDOCAINE; MEPOLIZUMAB; NEDOCROMIL; SIGLEC 8; UNCLASSIFIED DRUG; VINCRISTINE; ZILEUTON;

CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; COLITIS; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC GASTRITIS; EOSINOPHILIC GASTROENTERITIS; ESOPHAGITIS; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATION; LEUKOCYTE FUNCTION; NONHUMAN; PATHOGENESIS; REVIEW;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; ESOPHAGEAL DISEASES; GASTROENTERITIS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINE, SMALL; MICE; MODELS, ANIMAL;

EID: 33645379086     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-006-0013-8     Document Type: Review

References (54)

1. Moon A, Kleinman RE: Allergic gastroenteropathy in children. Ann Allergy Asthma Immunol 1995, 74:5-12.
2. Keshavarzian A, Saverymuttu SH, Tai PC, et al.: Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 1985, 88:1041-1049.
3. Sherman MP, Cox KL: Neonatal eosinophilic colitis. J Pediatr 1982, 100:587-589.
4. Furuta GT: Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr 1998, 26:468-471.
5. Fox VL, Nurko S, Furuta GT: Eosinophilic esophagitis. Gastrointest Endosc 2002, 56:260-270.
6. Walsh RE, Gaginella TS: The eosinophil in inflammatory bowel disease. Scand J Gastronenterol 1991, 26:1217-1224.
7. Winter HS, Madara JL, Stafford RJ, et al.: Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982, 83:818-823.
8. Brown LF, Goldman H, Antonioli DA: Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984, 8:899-905.
9. Rothenberg ME: Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004, 113:11-28.
10. Ngo P, Furuta GT, Burks AW: The pathobiology of eosinophilic gastroenteritis of childhood: Is it really the eosinophil, allergic mediated, or something else. Curr Gastroenterol Rep 2004, 6:436-440.
11. Caldwell JH, Tennerbaum JI, Bronstein HA: Serum IgE to eosinophilic gastroenteritis. N Engl J Med 1975, 292:1388-1390.
12. Cello JP: Eosinophilic gastroenteritis: a complex disease entity. Am J Med 1979, 67:1097-1114.
13. Scudamore HH, Phillips SF, Swedlund HA, Gleich GJ: Food allergy manifested by eosinophilia, elevated immunoglobulin E level, and protein-losing enteropathy: the syndrome of allergic gastroenteropathy. J Allergy Clin Immunol 1982, 70:129-136.
14. Iacono G, Carroccio A, Cavataiio F, et al.: Gastroesophageal reflux and cows milk allergy in infants: a prospective study. J Allergy Clin Immunol 1996, 97:822-827.
15. Walsh SV, Antonioli DA, Goldman H, et al.: Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 1999, 23:390-396.
16. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA: The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002, 109:363-368.
17. Kelly KJ, Lazenby AJ, Rowe PC, et al.: Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503-1512.
18. Sampson HA: Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999, 103:717-728.
19. Bates B: "Explosion" of eosinophilic esophagitis in children. Pediatr News 2000, 34:4-10.
20. Noel RJ, Putnam PE, Rothenberg ME: Eosinophilic esophagitis. N Engl J Med 2004, 351:940-941.
21. Simm D, Marti H, Heer P, et al.: Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 2005, 115:1090-1092.
22. Ahmad M, Soetikno RM, Ahmed A: The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol 2000, 30:242-244.
23. Orenstein SR, Shalaby TM, Di Lorenzo C, et al.: The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000, 95:1422-1430.
24. Fox VL, Nurko S, Teitelbaum JE, et al.: High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc 2003, 57:30-36.
25. Justinich CJ, Ricci A Jr, Kalafus DA, et al.: Activated eosinophils in esophagitis in children: a transmission electron microscopic study. J Pediatr Gastroenterol Nutr 1997, 25:194-198.
26. Jaffe J, James S, Mullins G, et al.: Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma interferon in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol 1994, 14:299-309.
27. Beyer K, Castro R, Birnbaum A, et al.: Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol 2002, 109:707-713.
28. Kelly KJ: Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 2000, 30(Suppl):S28-S35.
29. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR: Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990, 31:54-58.
30. Rothenberg ME, Mishra A, Brandt EB, Hogan SP: Gastrointestinal eosinophils in health and disease. Adv Immunol 2001, 78:291-328.
31. Van Sickle GJ, Powell GK, McDonald PJ, Goldblum RM: Milk- and soy protein-induced enterocolitis: evidence for lymphocyte sensitization to specific food proteins. Gastroenterology 1985, 88:1915-1921.
32. Guajardo JR, Rothenberg ME: Eosinophilic esophagitis, gastroenteritis, gastroenterocolitis, and colitis. In Food Allergy: Adverse Reactions to Foods and Additives, edn 3. Edited by Metcalfe DD, Sampson HA, Simon RA. Malden, MA: Blackwell Publishing; 2003:217-226.
33. Hendrickson BA, Gokhale R, Cho JH: Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002, 15:79-94.
34. Miner PB Jr: Seeing red in inflammatory bowl disease: the eosinophil at center stage? Inflamm Bowel Dis 2004, 10:329-330.
35. Carvalho AT, Elia CC, de Souza HS, et al.: Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003, 36:120-125.
36. Desreumaux P, Nutten S, Colombel JF: Activated eosinophils in inflammatory bowel disease: Do they matter? Am J Gastroenterol 1999, 94:3396-3398.
37. Forbes E, Murase T, Yang M, et al.: Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol 2004, 172:5664-5675.
38. Furuta GT, Ackerman SJ, Wershil BK: The role of the eosinophil in gastrointestinal diseases. Curr Opin Gastroenterol 1995, 11:541-547.
39. Hogan SP, Rothenberg ME, Forbes E, et al.: Chemokines in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep 2004, 4:74-82.
40. Dvorak AM, Onderdonk AB, McLeod RS, et al.: Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo. Int Arch Allergy Immunol 1993, 102:33-45.
41. Schappi MG, Smith VV, Milla PJ, Lindley KJ: Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003, 52:752-755.
42. Mishra A, Hogan SP, Brandt EB, Rothenberg ME: Interleukin-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002, 168:2464-2469.
43. Mishra A, Rothenberg ME: Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003, 125:1419-1427.
44. Akei HS, Mishra A, Blanchard C, Rothenberg ME: Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005, 129:985-994.
45. Garrett JK, Jameson SC, Thomson B, et al.: Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004, 113:115-119.
46. Noel RJ, Putnam PE, Collins MH, et al.: Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004, 2:568-575.
47. Rothenberg ME: Eosinophilia. N Engl J Med 1998, 338:1592-1600.
48. Stellato C, Matsukura S, Fal A, et al.: Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 1999, 163:5624-5632.
49. Schleimer RP, Bochner BS: The effect of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994, 94:1202-1213.
50. Bankers-Fulbright JL, Kephart GM, Loegering DA, et al.: Sulfonylureas inhibit cytokine-induced eosinophil survival and activation. J Immunol 1998, 160:5546-5553.
51. Hunt LW, Frigas E, Butterfield JH, et al.: Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol 2004, 113:853-859.
52. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME: Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003, 111:227-242.
53. Blanchard C, Mishra A, Saito-Akei H, et al.: Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy 2005, 35:1096-1103.
54. Hogan SP, Rothenberg ME: Review article: the eosinophil as a therapeutic target in gastrointestinal disease. Aliment Pharmacol Ther 2004, 20:1231-1240.